Name: UMIN ID:
Unique ID issued by UMIN | C000000001 |
---|---|
Receipt number | R000000002 |
Scientific Title | Concurrent Treatment of Osteoporosis for Prevention of Vertebral Fracture in Japan - Multi-center Randomized Trial with Arendoronate and alfa-calcidol - |
Date of disclosure of the study information | 2005/07/01 |
Last modified on | 2023/07/03 15:13:28 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2005/06/01 19:15:38 | ||
2 | Update | 2005/06/08 16:26:57 | Acronym Acronym |
|
3 | Update | 2005/08/17 16:47:28 | TEL Tel1 |
|
4 | Update | 2005/08/17 22:14:01 | Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 |
|
5 | Update | 2005/12/29 10:20:22 | Target sample size |
|
6 | Update | 2005/12/29 10:23:23 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
7 | Update | 2006/12/29 10:26:09 | Recruitment status |
|
8 | Update | 2008/12/09 07:58:56 | Address Address TEL Address Address TEL Address1 Tel1 |
|
9 | Update | 2023/06/28 10:37:48 | UMIN ID1 |
|
10 | Update | 2023/07/03 14:21:42 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Zip code Address Address TEL Last name of contact person Last name of contact person Zip code Organization Organization Address Name of primary person or sponsor Organization Post marketing survey by drug manufacture etc., specified by Japanese law. Organization Organization Address Address Tel |
|
11 | Update | 2023/07/03 14:40:46 | Recruitment status Date of IRB |
|
12 | Update | 2023/07/03 15:13:28 | Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |